1163158002: Product containing precisely aminophylline hydrate 225 milligram/1 each prolonged-release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing purine and/or purine derivative (product)\Product containing methylated xanthine derivative (product)\Product containing aminophylline (medicinal product)\Product containing only aminophylline (medicinal product)\Aminophylline only product in oral dose form\Aminophylline hydrate 225 mg prolonged-release oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing purine and/or purine derivative (product)\Product containing methylated xanthine derivative (product)\Product containing aminophylline (medicinal product)\Aminophylline-containing product in oral dose form\Aminophylline only product in oral dose form\Aminophylline hydrate 225 mg prolonged-release oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethylenediamine and/or ethylenediamine derivative (product)\Product containing aminophylline (medicinal product)\Product containing only aminophylline (medicinal product)\Aminophylline only product in oral dose form\Aminophylline hydrate 225 mg prolonged-release oral tablet
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing ethylenediamine and/or ethylenediamine derivative (product)\Product containing aminophylline (medicinal product)\Aminophylline-containing product in oral dose form\Aminophylline only product in oral dose form\Aminophylline hydrate 225 mg prolonged-release oral tablet
\Medicinal product categorized by structure\Product containing alkaloid (product)\Product containing methylated xanthine derivative (product)\Product containing aminophylline (medicinal product)\Product containing only aminophylline (medicinal product)\Aminophylline only product in oral dose form\Aminophylline hydrate 225 mg prolonged-release oral tablet
\Medicinal product categorized by structure\Product containing alkaloid (product)\Product containing methylated xanthine derivative (product)\Product containing aminophylline (medicinal product)\Aminophylline-containing product in oral dose form\Aminophylline only product in oral dose form\Aminophylline hydrate 225 mg prolonged-release oral tablet

\Product manufactured as oral dose form (product)\Aminophylline-containing product in oral dose form\Aminophylline only product in oral dose form\Aminophylline hydrate 225 mg prolonged-release oral tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4594429011 Aminophylline hydrate 225 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4594430018 Product containing precisely aminophylline hydrate 225 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Aminophylline hydrate 225 mg prolonged-release oral tablet	Is a	Aminophylline only product in oral dose form	true	Inferred relationship	Some
Aminophylline hydrate 225 mg prolonged-release oral tablet	Has manufactured dose form	Prolonged-release oral tablet	true	Inferred relationship	Some
Aminophylline hydrate 225 mg prolonged-release oral tablet	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Aminophylline hydrate 225 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Aminophylline hydrate	true	Inferred relationship	Some	1
Aminophylline hydrate 225 mg prolonged-release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Aminophylline hydrate	true	Inferred relationship	Some	1
Aminophylline hydrate 225 mg prolonged-release oral tablet	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Aminophylline hydrate 225 mg prolonged-release oral tablet	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4594429011	Aminophylline hydrate 225 mg prolonged-release oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4594430018	Product containing precisely aminophylline hydrate 225 milligram/1 each prolonged-release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core